Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also...
224 insider purchases on record · latest filing 2026-08-05.
Insiders have also filed 169 sale transactions at CAMP.